Advertisement

Surgery in Hyperthyroidism: Toxic Adenoma and/or Multinodular Goiter

  • Türkay Kırdak
Chapter

Abstract

Toxic multinodular goiter is observed in areas of endemic iodine deficiency and commonly in elderly individuals. Diagnosis and assessment are made easily by physical examination, serum thyroid function tests, ultrasonography, and scintigraphy. The disease presents with subclinical hyperthyroidism in a significant part of the patients. Radioactive iodine therapy and surgery are two basic treatment methods of the disease with specific advantages and disadvantages. Selection of the treatment method is made upon factors about the disease, patient, and physician. This paper presents a case with toxic nodular goiter and discusses treatment options.

Keywords

Hyperthyroidism Toxic multinodular goiter Toxic adenoma Surgery Thyroidectomy 

References

  1. 1.
    Bülow Pedersen I, Knudsen N, Jørgensen T, Perrild H, Ovesen L, Laurberg P. Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metab. 2002;87:4462–9.CrossRefGoogle Scholar
  2. 2.
    Nyirenda MJ, Clark DN, Finlayson AR, Read J, Elders A, Bain M. Thyroid disease and increased cardiovascular risk. Thyroid. 2005;15:718–24.CrossRefGoogle Scholar
  3. 3.
    Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med. 1990;89:602–8.CrossRefGoogle Scholar
  4. 4.
    Miller JM, Block MA. Functional autonomy in multinodular goiter. JAMA. 1970;214:535–9.CrossRefGoogle Scholar
  5. 5.
    Kang AS, Grant CS, Thompson GB, van Heerden JA. Current treatment of nodular goiter with hyperthyroidism (Plummer’s disease): surgery versus radioiodine. Surgery. 2002;132:916–23.CrossRefGoogle Scholar
  6. 6.
    Díez JJ. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology. 2003;49:316–23.CrossRefGoogle Scholar
  7. 7.
    Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med. 1998;338:712–8.CrossRefGoogle Scholar
  8. 8.
    Giesecke P, Rosenqvist M, Frykman V, Friberg L, Wallin G, Höijer J. Increased cardiovascular mortality and morbidity in patients treated for toxic nodular goiter compared to Graves’ disease and nontoxic goiter. Thyroid. 2017;27:878–85.CrossRefGoogle Scholar
  9. 9.
    Porterfield JR Jr, Thompson GB, Farley DR, Grant CS, Richards ML. Evidence-based management of toxic multinodular goiter (Plummer’s disease). World J Surg. 2008;32:1278–84.CrossRefGoogle Scholar
  10. 10.
    Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228–38.CrossRefGoogle Scholar
  11. 11.
    Donangelo I, Suh SY. Subclinical hyperthyroidism: when to consider treatment. Am Fam Physician. 2017;95:710–6.PubMedGoogle Scholar
  12. 12.
    Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343–421.CrossRefGoogle Scholar
  13. 13.
    Negro R, Valcavi R, Toulis KA. Incidental thyroid cancer in toxic and nontoxic goiter: is TSH associated with malignancy rate? Results of a meta-analysis. Endocr Pract. 2013;19:212–8.CrossRefGoogle Scholar
  14. 14.
    Gelmini R, Franzoni C, Pavesi E, Cabry F, Saviano M. Incidental thyroid carcinoma (ITC): a retrospective study in a series of 737 patients treated for benign disease. Ann Ital Chir. 2010;81:421–7.PubMedGoogle Scholar
  15. 15.
    Smith JJ, Chen X, Schneider DF, Nookala R, Broome JT, Sippel RS, et al. Toxic nodular goiter and cancer: a compelling case for thyroidectomy. Ann Surg Oncol. 2013;20:1336–40.CrossRefGoogle Scholar
  16. 16.
    Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.CrossRefGoogle Scholar
  17. 17.
    Holm LE, Lundell G, Israelsson A, Dahlqvist I. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism. J Nucl Med. 1982;23:103–7.PubMedGoogle Scholar
  18. 18.
    Schneider DF, Sonderman PE, Jones MF, Ojomo KA, Chen H, Jaume JC, et al. Failure of radioactive iodine in the treatment of hyperthyroidism. Ann Surg Oncol. 2014;21:4174–80.CrossRefGoogle Scholar
  19. 19.
    Nygaard B, Hegedüs L, Ulriksen P, Nielsen KG, Hansen JM. Radioiodine therapy for multinodular toxic goiter. Arch Intern Med. 1999;159:1364–8.CrossRefGoogle Scholar
  20. 20.
    Adam MA, Thomas S, Youngwirth L, Hyslop T, Reed SD, Scheri RP, et al. Is there a minimum number of thyroidectomies a surgeon should perform to optimize patient outcomes? Ann Surg. 2017;265:402–7.CrossRefGoogle Scholar
  21. 21.
    Bron LP, O’Brien CJ. Total thyroidectomy for clinically benign disease of the thyroid gland. Br J Surg. 2004;91:569–74.CrossRefGoogle Scholar
  22. 22.
    Bliss RD, Gauger PG, Delbridge LW. Surgeon’s approach to the thyroid gland: surgical anatomy and the importance of technique. World J Surg. 2000;24:891–7.CrossRefGoogle Scholar
  23. 23.
    Kark AE, Kissin MW, Auerbach R, Meikle M. Voice changes after thyroidectomy: role of external laryngeal nerve. Br Med J (Clin Res Ed). 1984;289:1412–5.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Endocrine Surgery, Department of SurgeryUludag University Faculty of MedicineBursaTurkey

Personalised recommendations